Militello John
See Remarks
Militello John has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 21, 2026.
On the most recent filing, Militello John is listed as See Remarks at ROCKET PHARMACEUTICALS, INC. Inside the rolling window, Militello John reported no open-market purchases and 5 open-market sales totaling $24K in RCKT. The largest disclosed transaction in the window is a sale of 3,726 RCKT shares on Feb 13, 2026, worth $12K.
Companies traded
Other insiders at RCKT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$24K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 14, 2025 | RCKT | Sale | $2K |
| Oct 14, 2025 | RCKT | Sale | $12K |
| Oct 14, 2025 | RCKT | Sale | $22K |
| Oct 14, 2025 | RCKT | Sale | $79K |
Frequently asked questions
How many SEC Form 4 filings has Militello John made?
Militello John has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Militello John trade?
Militello John has filed SEC Form 4 disclosures for 1 company, including RCKT.
When was Militello John's most recent SEC Form 4 filing?
Militello John's most recent SEC Form 4 filing on Tracefour is dated May 21, 2026.
What is Militello John's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Militello John is listed as See Remarks.
What is Militello John's total buy and sell value in the current window?
Inside the rolling retention window, Militello John bought $0 and sold $24K based on SEC Form 4 filings.
What was Militello John's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,726 RCKT shares on 2026-02-13, worth $12K, per SEC Form 4 filings.